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Introduction 
Patients report significant morbidity following community-acquired pneumonia (CAP); 70% report 
persistent symptoms and up to 50% impaired daily activity at 4 weeks post-discharge.1 Respiratory 
muscle weakness is one possible mechanism for delayed recovery. Inspiratory muscle training (IMT) 
increases strength and endurance of inspiratory muscles,2,3 with improvements in patient-reported 
outcomes in other conditions.4,5 
Aim 
To assess the tolerability of IMT in adults discharged from hospital with community-acquired 
pneumonia. 
Methods 
Patients hospitalised with a diagnosis of CAP between February 2017 and March 2018 were eligible 
for inclusion and convenience sampling was used for participant selection. Participants received an 
IMT device (POWERbreath KHP2) following familiarisation. Training frequency (twice daily) and load 
(50% PImax) were fixed, however training volume was incremental during weeks 1-3 (10, 20, 30 
breaths) and constant thereafter (30 breaths.) Participants were followed by combination of 
telephone and clinic visits for 9 weeks. Outcomes of interest were; utilisation of IMT device per 
protocol (defined as >94% training adherence), patient-reported IMT acceptability, and number of 
device-related side effects. Statistical analysis was conducted using Stata (version 15.1.) 
Outcome / Results 
Twenty-two participants were recruited; 16 were male (72.7%), mean age was 55.2years (range 
27.9-77.3.) Participants completed IMT per protocol in 72.7% cases. One unrelated, unexpected 
serious adverse event (death) occurred during follow-up and 3 participants active at this time were 
stopped from further IMT by research sponsor pending investigation. Two participants were lost to 
follow-up. Side effects during IMT were reported on 15 occasions across 22 participants over a total 
1183 training days. Reported side effects included chest pain (x2), cough (x1), dyspnoea (x4), and 
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dizziness (x8). All side-effects were rated grade 1 and did not prevent participants from continuing 
training. Participant-reported IMT acceptability, defined by participants rating training as both 
‘useful’ and ‘helpful’ at each follow-up contact, was 99.4%. 
Conclusions 
Inspiratory muscle training appears to be safe, tolerable, and acceptable to patients following CAP. 
Distinguishing CAP related symptoms and device-related side effects is challenging in patients 
recovering following an acute infective illness.   A clinical trial to determine efficacy is warranted. 
References 
1. Pick HJ, Bolton CE, Lim WS, McKeever TM. Recovery in adults hospitalised with community-
acquired pneumonia; a systematic review and meta-analysis. 
2. Enright SJ, Unnithan VB. Effect of inspiratory muscle training intensities on pulmonary 
function and work capacity in people who are healthy: a randomized controlled trial. Phys Ther 
2011; 91(6): 894-905. 
3. Mills DE, Johnson MA, Barnett YA, Smith WH, Sharpe GR. The effects of inspiratory muscle 
training in older adults. Med Sci Sports Exerc 2015; 47(4): 691-7. 
4. Marco E, Ramirez-Sarmiento AL, Coloma A, et al. High-intensity vs. sham inspiratory muscle 
training in patients with chronic heart failure: a prospective randomized trial. Eur J Heart Fail 2013; 
15(8): 892-901. 
5. Ramirez-Sarmiento A, Orozco-Levi M, Guell R, et al. Inspiratory muscle training in patients 
with chronic obstructive pulmonary disease: structural adaptation and physiologic outcomes. Am J 
Respir Crit Care Med 2002; 166(11): 1491-7. 
 
